Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
종목 코드 INBS
회사 이름Intelligent Bio Solutions Inc
상장일Dec 23, 2020
CEOMr. Harry Simeonidis
직원 수16
유형Ordinary Share
회계 연도 종료Dec 23
주소135 W 41St St,
도시NEW YORK
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호10036
전화16467905756
웹사이트https://ibs.inc/
종목 코드 INBS
상장일Dec 23, 2020
CEOMr. Harry Simeonidis
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음